Prothrombin Shanghai: Hypoprothrombinaemia caused by substitution of Gla29 by Gly

Haemophilia

Volumn 10, Issue 1, 2004, Pages 94-97

  Wang, W ^a   Fu, Q ^a   Zhou, R ^a   Wu, W ^a   Ding, Q ^a   Hu, Y ^a   Wang, X ^a   Wang, Hongli ^a   Wang, Z ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Deficiency; Gene mutation; Prothrombin

Indexed keywords

4 CARBOXYGLUTAMIC ACID; ANTIGEN; BLOOD CLOTTING FACTOR; CALCIUM BINDING PROTEIN; DNA; GLUTAMINE; GLYCINE; PROTHROMBIN;

AMINO ACID SUBSTITUTION; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; BLEEDING DISORDER; BLOOD CLOTTING TEST; CARBOXYLATION; CASE REPORT; CHINESE; FAMILY; FEMALE; GENE AMPLIFICATION; GENETIC DISORDER; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPOPROTHROMBINEMIA; MEMBRANE TRANSPORT; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PARTIAL THROMBOPLASTIN TIME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTHROMBIN TIME; RESTRICTION MAPPING; SCHOOL CHILD;

EID: 1042292587     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2003.00838.x     Document Type: Article

References (12)

1. Davie EW, Fujikawa K, Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 1991; 30: 10363-70.
2. Akhavan S, Luciani M, Lavoretano S, Mannucci PM. Phenotypic and genetic analysis of a compound heterozygote for dys- and hypoprothrombinaemia. Br J Haematol 2003; 120: 142-4.
3. Sun WY, Smirnow D, Jenkins ML, Degen SJ. Prothrombin Scranton: substitution of an amino acid residue involved in the binding of Na+ (LYS-556 to THR) leads to dysprothrombinemia. Thromb Haemost 2001; 85: 651-4.
4. Degen SJF, Davie EW. Nucleotide sequence of the gene for human prothrombin. Biochemistry 1987; 26: 6165-77.
5. Poort SR, Landolfi R, Bertina RM. Compound heterozygosity for two novel missense mutations in the prothrombin gene in a patient with a severe bleeding tendency. Thromb Haemost 1997; 77: 610-5.
6. Jennifer V, Ratcliffe S, Furie B. The importance of specific γ-carboxyglutamic in prothrombin, evaluation by site-specific mutagenesis. J Biol Chem 1993; 268: 24339-45.
7. Blostein MD, Rigby AC, Jacobs M, Furie B, Furie BC. The Gla domain of prothrombin has a binding site for factor Va. J Biol Chem 2000; 275: 38120-6.
8. Strijks E, Poort SR, Renier WO, Gabreels FJ, Bertina RM. Hereditary prothrombin deficiency presenting as intracranial haematoma in infancy. Neuropediatrics 1999; 30: 320-4.
9. Millar DS, Kemball-Cook G, McVey JH et al. Molecular analysis of the genotype-phenotype relationship in factor VII deficiency. Hum Genet 2000; 107: 327-42.
10. Giannelli F, Green PM, Sommer SS et al. Haemophilia B (sixth edition): a database of point mutations and short additions and deletions. Nucleic Acids Res 1996; 24: 103-18.
11. Kim DJ, Thompon AR, James HL. Factor X Ketchikan: a variant molecular in which Gly replaces a Gla residue at position 14 in the light chain. Hum Genet 1995; 95: 212-4.
12. Watzke HH, Lechner K, Roberts HR et al. Molecular defect (Gla + 14 → Lys) and its functional consequences in a hereditary factor X deficiency (Factor X 'Vorarlberg'). J Biol Chem 1990; 265: 11982-9.